Iwaki Seiyaku

Iwaki Seiyaku is owned by Iwaki.

Iwaki is a company listed under the stock ticker 6237 (JP).

They are in:

• Retail33%
• Pharmaceuticals33%
• Other33%

View the org chart displaying its 5 main executives

Most searched biographies at Iwaki Seiyaku

• Taisuke Nishimura, President, Chief Executive Officer and General ...
• Toshimitsu Isobe, Director
• Keitaro Iwaki, Chairman of the Board

Create your alert
to follow the executive moves at Iwaki Seiyaku.

Iwaki has 1,861 competitors including Pfizer (United States (USA)), Sanofi (France) and Johnson & Johnson (United States (USA)).

Popular M&A news in Pharmaceuticals

• MedMen has filed for bankruptcy protection  (posted on April 28 2024).
• AstraZeneca has announced the acquisition of Fusion Pharma  (posted on March 23 2024).
• AstraZeneca has announced the acquisition of Amolyt Pharma  (posted on March 19 2024).

Popular contacts in Pharmaceuticals

• Jean-Frédéric Paulsen - Executive Chairman of the Board at Ferring Pharmaceuticals
• Thierry Abribat - Chief Executive Officer at Amolyt Pharma
• Emma Walmsley - Chief Executive Officer and Director at GSK

Learn more about the Pharmaceuticals industry >

Press releases by Iwaki Seiyaku

Social media about Iwaki Seiyaku

• Iwaki Seiyaku on Wikipedia, Google News & Yahoo Finance
• Iwaki Seiyaku on LinkedIn, Twitter & YouTube

Contact by email its executives including Taisuke Nishimura

Call Iwaki Seiyaku at +81 33...

View the org chart

Register to receive your alert

Report an error